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Splenic  lymphocytes from responder  mice that  are  immune to  the  random  ter- 
polymer of e-glutamic acidn°-L-alanine3°-L-tyrosine  1° (GAT) 1, an antigen under H-2- 
linked  immune response  (Ir)  gene control,  develop  secondary plaque-forming cell 
(PFC)  responses preferentially when stimulated in vitro with GAT-bearing macro- 
phages (Mq~) syngeneic to the Mq~ used to present GAT to the spleen cells during the 
immunization process in vivo (1-4).  This preference or genetic restriction has been 
demonstrated with spleen cells  from mice which are responders to GAT and which 
have been immunized with either syngeneic or allogeneic responder or nonresponder 
GAT-M~  (2,  3).  These  restrictions  are  antigen-specific,  operate  at  the  level  of 
interactions between GAT-Mq~ and the immune helper T  cell, and are mediated by 
products of the I-A subregion of the H-2 complex  (4).  2 Similar genetic restrictions 
have been observed in M~-T-cell interactions in other responses, such as the generation 
and functional expression of carrier-specific murine helper T  cells in vitro (5), DNA 
synthetic responses to antigen by immune guinea pig (6) and murine (7) T  lympho- 
cytes, and the expression of delayed hypersensitivity reactions in mice (8). Primary 
IgG PFC responses to GAT are not governed by restrictions of M~-T-cell interactions 
(2,  3),  however, genetic restrictions  have been  noted in  primary IgM  responses  to 
other antigens under H-2-1inked Ir gene control, such as poly-L-(tyrosine, glutamic 
acid)-poly-DL-alanine-poly-L-lysine [T,G]-A-L (9). 
Although  lymphoid cells  from  mice  immune  to  GAT  develop  secondary  PFC 
responses to GAT-M~ syngeneic with the Mq~ used for in vivo immunization, minimal 
PFC responses develop when these immune lymphoid cells are stimulated by GAT- 
M~ allogeneic to those used for immunization. This is most apparent when C57BL/10 
mice are immunized in vivo with allogeneic DBA/1 GAT-Mq~ and develop secondary 
PFC responses in vitro when stimulated with DBA/1 GAT-Mq~, but fail to develop a 
significant  response  when  stimulated  with  syngeneic  C57BL/10  GAT-M4~.  It  is 
unlikely that this failure to respond to syngeneic GAT-Mq~  is due to an absence of 
virgin unrestricted GAT-specific helper T  cells in spleens of these mice 2-8 wk after 
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a  single immunization with  3-4  ×  10  ~ allogeneic GAT-Mq~ bearing ~  100-150 ng 
GAT. Thus, we investigated whether suppressor cells are present in these genetically 
restricted immune lymphoid cells and whether these suppressor cells may account for 
the  failure of immune spleen cells to  develop primary PFC  responses to  GAT-Mdp 
allogeneic to the M~ used for the initial immunization in vivo. These investigations 
are the subject of this communication. 
Materials and Methods 
Mice.  C57BL/10 (H-2b), C3H/He (H-2k), B10.D2  (H-2a), DBA/2 (H-2a), and DBA/1  (H- 
2q) mice were bred in the Animal Facility in the Yalem Building at The Jewish Hospital of St. 
Louis. All mice were maintained on laboratory chow and water ad libitum and used at  10-20 
wk old. In a single experiment, mice were sex- and age-matched. DBA/1 mice are nonresponders 
to GAT; all other mice are responder strains. 
Antigens.  GAT (Miles Laboratories Inc., Miles Research Products, Elkhart, Ind.; lot 4, mol 
wt  ~45,000)  was  prepared  as  previously described  for  use  as  antigen in  culture  (10),  for 
preparing GAT-Mdp (2), and for coupling to sheep  erythrocytes (SRBC)  for use as indicator 
cells in the PFC assay  (10). SRBC  (Grand Island Biological  Co.,  Grand Island, N.  Y.)  were 
prepared  for  use  as  antigen in culture and  indicator cells  in the  PFC  assay  as  previously 
described (11). 
Culture System and Hemolytic Plaque Assay.  Single-cell suspensions of spleen, at 107 cells/ml (or 
at  other cell  densities as  indicated), in completely supplemented Eagle's minimal essential 
medium containing 10% fetal  calf serum (Reheis Chemical Co.,  Division of Armour Pharma- 
ceutical Co., Chicago, Ill.; lot M26302)  were incubated as  1-ml cultures with GAT, GAT-Mq~, 
or SRBC for 5 days under modified Mishell-Dutton conditions (2,  11). Deviations from this 
protocol and separation and treatment of Mq~, T-cell, and B-cell  populations are described 
below.  IgM  and IgG  PFC  responses  to  SRBC  and IgG GAT-specific PFC  responses  were 
assayed using the slide modification of the Jerne hemolytic plaque assay (10, 11). Viable cell 
recovery  was  monitored  using  trypan  blue  dye  exclusion  and  a  Cytograf 6300A  (Ortho 
Instruments, Westwood, Mass.). 
Preparation of GA T-Md  O  and Immunization of Mice.  The preparation of GAT-M@ using peptone- 
induced peritoneal exudate has been described in detail previously (2,  12). C57BL/10 mice 
6  were immunized by a single intraperitoneal injection of 3-4  X  10 ' of the indicated GAT-M~ 
6  125  bearing ~20-30 ng GAT/10  cells as quantitated by  I-GAT bound to Mdo (12). Spleen cells 
from  these  mice were  used  in culture 21-35  days  later.  GAT-M~ for  stimulation of PFC 
responses in vitro were prepared identically and 7 or 5  ×  104 M@ bearing -~1-2 ng GAT were 
added to culture. In some experiments, peritoneal exudate Mff were treated with anti-Thy 1.2 
sera and guinea pig complement (C) (lacking nonspecific cytotoxic activity on murine cells) to 
deplete T  cells or  1,000 rads X-irradiation before pulsing with GAT. Other GAT-M4~ were 
incubated after pulsing for 24 h at 37°C in 5% CO2 in air, washed, and then used to stimulate 
PFC responses  in culture (aged GAT-Mff). Md~ content in the various GAT-Mq~ preparations 
was monitored by latex sphere ingestion. Freshly pulsed GAT-Mff preparations had a minimum 
of 85% phagocytic cells; anti-Thy 1.2  +  C treated and aged GAT-Mq~ preparations had ->90% 
and _>95% phagocytic cells, respectively. 
Preparation of T- and B-Cell Populations.  Spleen cells from immunized mice were fractionated 
into T- and B-cell populations by a modification of the technique of Schlossman and Hudson 
(13). Immunoadsorbents were prepared by conjugation of the immunoglobulin  (Ig) fraction of 
high  titer,  polyvalent rabbit  anti-mouse Ig  sera  to  CNBR-Sepharose  4B  (Pharmacia  Fine 
Chemicals,  Div.  of  Pharmacia  Inc.,  Piscataway,  N.  J.)  according  to  the  manufacturer's 
directions. Conditions were adjusted empirically to yield 2 mg protein/ml packed Sepharose. 
Spleen cells  at  20  ×  106  cells/ml in L-15  (Microbiological Associates,  Walkersville, Md.), 
containing  5% fetal calf serum, 2.5 mM EDTA and 50 U/ml each penicillin and streptomycin, 
were  applied  to  the  immunoadsorbent columns  at  4°C.  The  maximum  capacity  of  the 
immunoadsorbent was  150  ×  106 spleen cells/ml Sepharose.  T  cells were  recovered from the 
column by addition of the EDTA medium until the effluent was  free of cells. Mechanically 
trapped T  cells and loosely adherent B cells were removed by gentle mixing of the Sepharose 
and washing with additional EDTA medium. The B cells adherent to the immunoadsorbent CARL  W.  PIERCE  AND JUDITH  A.  KAPP 
TABLE  I 
Suppressor Cell Activity in Immune Spleen Cells Restricted  for Allogeneic GA T-M(a 
1273 
C57BL/10 Spleen cells 
(×  10-n)/cuhure  Day 5 IgG GAT-specific PFC/cuhure* 
DBA/1 GAT-  C57BL/10  DBA/I  Me  C3H/He M~ 
Virgin  Mq~ Primed$  Mth 
Experiment 
10 
12 
16 
10 
10 
Experiment 
10 
12 
16 
10 
10 
--  430  695  755 
--  515  535  465 
--  600  465  475 
10  50  545  10 
2  770  605  310 
6  170  710  150 
--  880  780  930 
--  810  870  1,020 
--  620  620  690 
10  80  780  20 
2  50  640  10 
6  30  510  <10 
* The indicated numbers of virgin or immune C57BL/10 spleen cells were cultured with 7 
×  l04 of the indicated GAT-Mtb bearing ='2 ng GAT. 
$ C57BL/10 mice were immunized  28  (exp.  l)  or 35  (exp. 2)  days previously by intraperi- 
toneal injection of 3  ×  106 DBA/1 GAT-Mtb bearing 130 ng GAT/106 ceils. At culture 
initiation, these spleen cells had <25 IgG GAT-specific PFC/107 cells. 
were eluted with EDTA  medium  containing  10%  vol/vol  mouse serum  as a  source of gamma 
globulin. This procedure routinely yielded recovery of 80-90% of the applied spleen cells; ~35% 
were collected  in the T-cell  fraction,  45%  in the  B-cell  fraction,  and  20%  in the  intermediate 
fraction  which  was  discarded.  The  T-cell  fraction  contained  <--2% Ig  +  cells  and  the  B-cell 
fraction  was  75-85%  Ig  +  cells.  In  some  experiments,  immune  spleen  cells  were  treated  with 
anti-Thy  1.2  serum  and  (2  to  deplete  T  cells  or  800  rads  X-irradiation  to  inactivate  B-cell 
function  and determine radiosensitivity of T-cell functions. 
Results 
Demonstration of Suppressor Cells in Immune Spleen Cells whose PFC Responses are Restricted 
for the Immunizing Mch.  These experiments are based first on the observation that Mq~- 
lymphocyte  interactions  in  primary  PFC  responses  of virgin  spleen  cells  are  not 
governed by genetic restrictions  (2, 3); syngeneic and allogeneic GAT-Mq~ stimulate 
comparable primary IgG GAT-specific PFC responses by virgin spleen cells  (Tables 
I-V).  Second,  immune  spleen  cells  develop  secondary  PFC  responses  only  when 
stimulated in vitro with GAT-M~ syngeneic to those which presented the GAT during 
the  immunization  process  in  vivo,  whether  these  M~  are  allogeneic  (Table  I)  or 
syngeneic  (Tables  II-V)  to  the  responding  lymphoid  cells.  In  these  experiments, 
suppressor cell  activity  was assessed  by  adding graded  numbers of these restricted 
immune spleen cells to 107 unrestricted virgin spleen cells which were then stimulated 
by a panel of syngeneic and allogeneic GAT-Mq~. Suppressor cells were demonstrated 
in immune spleen cells  restricted  for both allogeneic  (Table I) and syngeneic  (Table 
II) GAT-Mq~. Thus, immune spleen cells responded to the GAT-Mq~ used for priming 
in vivo, but had cells capable of suppressing primary PFC responses by virgin spleen 
cells  stimulated  with  GAT-Mth  allogeneic  to  those  used  for  priming.  Generally, 
significant  suppression was observed with  2  ×  106 immune spleen  cells,  however, 1274  SUPPRESSOR  T  CELLS AND  RESTRICTIONS IN IMMUNE  RESPONSES 
TABLE II 
Suppressor Cell Actwity in Immune Spleen Cells Restricted  for Syngeneic GA T-Mq~ 
C57BL/10 Spleen cells 
(X lO-6)/culture  Day 5 IgG PFC/culture* 
GAT-specific  vs. SRBC 
C57BL/10 
Virgin  GAT-Mq~  C57BL/10  DBA/1  B10.D2  C57BL/10  DBA/1 
Primed~  Mq~  Mq~  M~  GAT-Mq~  GAT-M4~ 
+  SRBC  +  SRBC 
10  --  900  1,140  1,060  260  310 
12  --  770  690  850  350  515 
16  --  310  385  315  470  520 
--  10  1,060  80  110  260  520 
10  2  770  140  10  465  595 
* The indicated number of virgin or immune C57BL/10 spleen cells were cultured with 7 ×  104 of the 
indicated GAT-Mq~  bearing m2 ng GAT, or GAT-M~ plus 5 ×  106 SRBC. 
:~ C57BL/10 mice were immunized 28 days previously by intraperitoneal injection of 3 ×  106 C57BL/10 
GAT-M¢ bearing m30 ng GAT/106 cells. At culture initiation, these spleen cells had <25 IgG GAT- 
specific PFC/107 cells. 
occasionally larger numbers of cells were required  to achieve significant suppression 
(Table I, exp.  1). Suppressor cell activity was always observed with third party GAT- 
Mq~  (C3H/He  Mq~  in  Table  I  and  B10.D2  Mq~  in  Table  II)  unrelated  by  H-2 
haplotype  to  either  the  responding  spleen  cells  or  the  GAT-Mq~  used  for  in  vivo 
priming.  The suppression  was antigen-specific;  primary  IgM  (data  not  shown)  and 
IgG PFC responses to SRBC were not suppressed  by the immune spleen cells in the 
presence of GAT-M$ which induced suppression of the GAT-specific primary response 
(Table II). 
Characterization of the Suppressor Cell.  The suppressor cells  in  genetically restricted 
immune  spleen  cells  were  characterized  as  T  cells  by two  methods.  First,  immune 
spleen  cells  were separated  into T  and  B  cells  by adsorption  to and  elution  from a 
rabbit  anti-mouse  Ig Sepharose  4B column  (Table  III). Purified  T  cells,  but  not  B 
cells, suppressed responses of virgin spleen cells stimulated  by GAT-Mq~ allogeneic to 
those  used  to prime  the  restricted  immune  spleen  cells.  Here,  C57BL/10  GAT-Mq~ 
were used  for immunization  and  DBA/1  GAT-M4~ elicited  suppressor  cell  activity. 
Second, the suppressive  activity in restricted  immune spleen  cells was abrogated by 
treatment with anti-Thy 1.2 serum plus C demonstrating, by a subtractive procedure, 
that the suppressor cells are T  cells (Table IV). Lastly, suppressor T-cell function was 
radiosensitive,  because  800  rads  X-irradiation  abolished  their  activity  (Table  IV). 
Thus,  suppressor  cell  activity  in  restricted  immune  spleen  cells  is  a  property  of 
radiosensitive,  antigen-specific T  cells. 
Allogeneic  T  Cells  Contaminating  the  GAT-M¢~  are  not  Responsible  for  the 
Suppression.  Suppressor  T  cells  in  immune  spleen  cells  that  are  restricted  for  the 
ailogeneic GAT-M~ are stimulated  by syngeneic GAT-Mq~ in  vitro  (Table  I); here, 
exposure to allogeneic cells is limited  to the in vivo immunization process.  However, 
suppressor  T  cells  in  immune  spleen  cells  restricted  for  syngeneic  GAT-Mq~  are 
activated by allogeneic GAT-Mq~ in vitro (Table II) where the exposure to allogeneic 
cells  is during  the culture  and  the contribution  of allogeneic  T  cells contaminating 
the Mq~ preparation  to the suppressive activity is important  to determine.  Thus, M~ CARL  W.  PIERCE  AND JUDITH  A.  KAPP 
TABLE  III 
Suppressor Cell Activity in Restricted  Immune  Spleen Cells is a Function of T  Cells 
1275 
C57BL/10 Spleen cells  (x lO-e')/cuhure 
C57BL/10 GAT-Mq~ primed:J: 
Day 5 IgG GAT-specific 
PFC/culture* 
Virgin  Spleen  T  Cells  B Cells  C57BL/10 M~  DBA/I Md~ 
Cells 
10  --  --  --  930  990 
12  --  --  --  750  800 
--  10  --  --  810§  <10 
10  2  --  --  760  40 
--  --  10  --  100§  NDII 
--  --  --  10  70§  ND 
--  --  5  5  630§  40 
10  --  2  --  570  70 
10  --  --  2  520  570 
* The indicated numbers of virgin or immune C57BL/10 spleen cells or purified T  or B cells 
were cultured with 7  ×  104 C57BL/10 or DBA/1 GAT-Mq~ bearing m2 ng GAT. 
:~ C57BL/10  mice were immunized 35  days previously by intraperitoneal  injection of 3  × 
106 GAT-Mq~ bearing ~30 ng GAT/106 ceils. At culture initiation, spleen cells  from these 
mice had <30 IgG GAT-specific PFC/107 cells. T  and B cells were prepared as described 
in Materials and Methods. 
§ PFC responses to SRBC: Spleen cells-IgM-2,550, IgG-290; T  cells-IgM-300, IgG-0; B cells- 
IgM-330, IgG-0; T  cells  +  B eells-IgM-1,830,  IgG-210. 
II ND, not done. 
TABLE  IV 
Radiosensitivity  of Suppressor T  Cells in Restricted Immune Spleen Cells 
C57BL/10 Spleen cells  (× 10-°)/culture 
Virgin 
C57BL/10 GAT-Mq~ primed* 
Day 5 IgG GAT-specific 
PFC/culture:~ 
C57BL/10  DBA/1 M~ 
Spleen  Anti-Thy  X-irradi-  Mth 
I+C 
cells  ated 
treated 
10  --  --  --  980  990 
12  --  --  --  930  1,050 
--  10  --  --  980  70 
10  2  --  --  1,270  290 
-  -  to  -  90  ND§ 
--  --  --  10  <10  ND 
--  --  5  5  930  ND 
10  --  2  --  1,340  1,060 
10  --  --  2  1,160  1,450 
* C57BL/10  mice were immunized 35 days previously by intraperitoneal injection of 3  × 
10  n C57BL/10 GAT-Mq~ bearing ~25 ng GAT/10  e cells. At culture initiation, spleen cells 
from these mice had <30 IgG GAT-speeific PFC/107 cells.  Spleen cells were treated with 
anti-Thy 1 +  C or irradiation as described in Materials and Methods. 
:[:The  indicated  numbers of virgin or  immune C57BL/10  spleen  cells,  anti-Thy  1  +  C 
treated, or X-irradiated  (800  rads) spleen ceils were cultured with 5  ×  104 C57BL/10 or 
DBA/I GAT-Mq~ bearing I1 ng GAT. 
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TABLE V 
T  Cells Contaminating  Allogeneic  GA T-M~ Preparations  are not Responsible for Suppression  Mediated by 
Immune Spleen  Cells Restricted for Syngeneic Mdp 
C57BL/10 Spleen cells 
(× 10-6)/culture 
C57BL/10 
Virgin  GAT-M@ 
Primed§ 
Day 5 IgG GAT-specific PFC/culture* 
C57BL/10 Mth:~  DBA/2 M4~: 
Anti-Thy 1  Anti-Thy 1 
Normal  +  C  Aged  Normal  +  C  Aged 
Treated  Treated 
10  --  360  360  300  350  360  290 
12  --  330  300  290  280  2~)  220 
--  10  260  200  230  30  <10  50 
10  2  280  300  250  50  10  <10 
* Virgin or immune C57BL/10 spleen cells were incubated with 5 ×  104 C57BL/10 or DBA/2 GAT-Mq~ 
treated as described in Materials and Methods. Normal and anti-Thy  1 +  C treated M~b had -~2 ng 
GAT/105 Mq~; aged Mq~ had ='0.2 ng GAT/10  ~ Mq~. 
~: On the basis of latex bead ingestion, normal M# were a85% phagocytic; anti-Thy  1 +  C treated M~ 
were 90% phagocytic; and aged Mq~ were >95% phagocytic. 
§ C57BL/10 mice were immunized 35 days previously by intraperitoneal injection of 4 ×  10  ~ C57BL/10 
GAT-M~ bearing =30 ng GAT/106 ceils. 
populations were treated with anti-Thy  1.2 serum plus C  before pulsing with GAT to 
deplete  T  cells  under the same conditions used  in Table  IV to deplete  T  cells  from 
immune spleen  cell populations.  The resulting  M4~ preparations  were --90%  phago- 
cytic by latex bead ingestion and bound approximately equivalent amounts of GAT 
as normal control  M~,  i.e.,  "2  ng/105 cells.  Normal and T-cell-depleted  C57BL/10 
and  DBA/2  GAT-M~  stimulated  comparable  primary  PFC  responses  by  virgin 
C57BL/10  spleen  cells,  secondary  responses  by  immune  spleen  cells  restricted  for 
syngeneic  C57BL/10  GAT-Mq~,  and  suppressor  cell  activity  in  primary  responses 
when  these  immune cells were stimulated  with  allogeneic  DBA/2 GAT-M~  (Table 
V).  Identical  results  were obtained  with  M~ preparations  X-irradiated  (1,000  rads) 
before pulsing with GAT (data not shown).  Another more indirect  approach  to this 
question  used GAT-Mq~ which had been aged after pulsing.  The T-cell depletion  in 
this situation is by attrition,  because the GAT-Mqb are incubated in medium without 
serum in 5% CO2 in air for 24 h. Few cells are lost by adherence to the plastic culture 
tubes  and  the  recovered cells  are  routinely  95%  phagocytic.  However,  --90% of the 
GAT  originally  associated  with  the  M~  is  released  into  the  supernate  as  nonacid 
precipitable radioactivity and the Mq~ retain --0.2 ng GAT/10  ~ cells (14). Nevertheless, 
these aged GAT-Mq~ behaved  identically  to freshly pulsed  or T-cell-depleted  GAT- 
M~b  in  terms  of their  ability  to  stimulate  primary  responses  by  virgin  spleen  cells, 
restricted responses by immune cells, and suppressor T-cell activity (Table V). Thus, 
T  cells contaminating the allogeneic peritoneal exudate M~ preparations  used in the 
various protocols do not appear to contribute either to the restrictions on Mq~-immune 
T-lymphocyte interactions in secondary PFC responses or the activation of suppressor 
T  cells in these immune spleen cells by an inappropriate  GAT-M4~. Moreover, these 
results  have been derived  using whole unfractionated  spleen  cells  rather  than  rigor- 
ously Mq~-depleted lymphoid cell populations, because depletion of Mdp does not alter 
the results.  Further, the experiments described in Tables III-V have been carried out CARL W.  PIERCE  AND JUDITH  A.  KAPP  1277 
with identical results using spleen cells from mice immunized with allogeneic GAT- 
M~  where  secondary  responses  are  restricted  to  those  allogeneic  GAT-M~,  and 
suppressor cells are stimulated by syngeneic GAT-M~ (data not shown). 
Discussion 
These experiments further characterize the immunological consequences of immu- 
nizing responder mice with GAT bound to syngeneic or allogeneic Mth.  As shown 
previously, virgin responder spleen cells develop comparable primary PFC responses 
to syngeneic or allogeneic GAT-Mth, whereas immune spleen cells develop secondary 
PFC  responses only when stimulated with GAT-Mth which are syngeneic with the 
M@ that presented GAT to the virgin lymphocytes during the immunization process 
in vivo (2, 3). In this system, no difference between responder and nonresponder M@, 
with regard to their ability to present GAT in an immunogenic form to lymphoid 
cells,  has  been  detected.  A  primary  objective  of the  present  experiments  was  to 
determine whether  suppressor  T  cells are  involved in  these  genetic  restrictions  in 
secondary responses and account for the failure of immune spleen cells, which should 
contain  virgin  unrestricted  GAT-specific  helper  T  cells,  to  develop  primary  PFC 
responses to GAT-Mth allogeneic to M~ used for in vivo immunization. 
Cultures  containing  small  numbers  of spleen  cells  primed  with  syngeneic  or 
allogeneic  GAT-M~  plus  virgin  spleen  cells  develop  responses  only  to  GAT-M~ 
syngeneic to the priming M~ and have suppressed  primary responses  to GAT-Mth 
allogeneic to the priming M~. Thus, these primed spleen cells contain helper T  cells, 
whose  function  is  genetically restricted  for the  priming  M~,  and  suppressor  cells, 
whose function is apparently not restricted, that inhibit the responses of virgin spleen 
cells.  The  suppression  is  specific  for GAT  because  no  suppression  of responses  to 
SRBC is observed in the presence of GAT-M@ which activate the suppressor cells. 
The suppression is mediated by T cells from GAT-Mth primed mice and this suppressor 
T-cell  function  is  relatively  radiosensitive.  Lastly,  the  possibility  that  a  negative 
allogeneic effect (15) mediated by T cells contaminating the Mth preparations causing 
either the restriction in secondary responses or the suppression in primary responses 
has been ruled out. 
These experiments also provide an explanation for the previous failure to demon- 
strate GAT-specific suppressor T cells in responder mice using experimental protocols 
which readily induce suppressor T cells in mice which are nonresponders to GAT (14, 
16,  17). First, in nonresponder mice soluble GAT induces suppressor T  cells which 
inhibit primary GAT-specific responses to GAT-MBSA in the presence of syngeneic 
Mth; GAT-M~ are ineffective activators of these suppressor T  cells, but can induce 
GAT-specific helper T  cells  (14,  18). In responder mice, GAT-Mth and soluble GAT 
induce both restricted helper T  cells and suppressor T  cells which are only activated 
by GAT-Mth allogeneic to the Mth present during the in vivo priming. Second, the 
kinetics of development of suppressor T  cells  differs in responder and nonresponder 
mice; suppressor T  cells are detected from 3 to 28 days after the injection of GAT in 
nonresponder mice (14, 16), but only 21 or more days after the injection of GAT-Mth 
in responder mice (C. W. Pierce, and J. A. Kapp, unpublished observations). Thus, 
GAT-specific suppressor T cells in responder and nonresponder mice appear to differ 
in both their mode and kinetics of activation. However, their mechanism of action 
may be similar, because they inhibit activation of virgin, but not immune, helper T 1278  SUPPRESSOR  T CELLS AND RESTRICTIONS IN IMMUNE RESPONSES 
cells. 3 Further studies comparing the mechanism(s) of action of suppressor T  cells in 
responder and nonresponder mice are currently in progress. 
GAT-specific suppressor T  cells induced in responder mice by immunization with 
GAT-Mth have not yet been characterized by Ly phenotype. Based on the observations 
that  GAT-specific suppressor T  cells  in  nonresponder mice express the  Ly  1-  23  + 
phenotype,  4 it might be predicted that suppressor cells in responder mice will express 
the same Ly phenotype. However, the recent report by Eardley et al. (19) demonstrat- 
ing that antigen-primed Ly 1  + T  cells function as helper cells for B-cell responses and 
also act  with  Ly  123  + T  cells to initiate a  feedback-suppressor cell loop, make the 
determination of the Ly phenotype on these suppressor T  cells mandatory. Moreover, 
the investigation of feedback suppressor loops and regulatory interactions among T 
cells  of the  various  Ly  phenotypes  in  responder  and  nonresponder  mice  may  be 
revealing with regard to the precise nature of the Ir gene defect in nonresponder mice. 
The observation that the development of genetic restrictions governing Mth-immune 
helper T-cell interactions correlates with  the  development of specific suppressor T 
cells  in  GAT-M@  primed  responder  mice  raises  the  issue  of whether  GAT-Mth 
stimulate  a  population of genetically restricted helper T  cells and  a  population of 
antigen-specific,  but  genetically  unrestricted,  suppressor  T  cells,  or,  whether  the 
genetic restrictions in helper T-cell function are mediated by the suppressor T  cells. 
The former possibility suggests first, that GAT-Mth induce expansion of the clones of 
T  cells  that  recognize GAT  in  the  context of I-A subregion  products  on  the  Mth 
membrane and that function as restricted helper cells only when re-exposed to those 
GAT-Mth. This concept makes no prediction about the nature of the T-cell receptor 
in terms of dual recognition vs. altered self or complex antigenic determinant models. 
Second, suppressor T  cells appear to be activated by the GAT alone and not by GAT 
in  the context of a  macrophage membrane complex. This concept is supported by 
observations  that  suppressor  T  cells  are  induced  in  vitro  by  soluble  antigen  in 
rigorously M@depleted T  cell cultures (20), and that the suppressor T  cells described 
here are activated by any GAT-MqJ which are allogeneic to the priming Mq~. Thus, 
the restricted immune helper T  cells would be resistant to the effects of the suppressor 
T cells which only inhibit the activation of virgin helper cells. Alternatively, the latter 
possibility suggests primed helper T  cells are not  themselves restricted, but  appear 
restricted because the suppressor T  cells inhibit the function of those helper T  cells 
activated by all GAT-Mq~ other than those used for immunization.  Experiments to 
distinguish between these two alternatives are currently in progress. 
Restrictions  mediated  by  products  of the  H-2  gene  complex  governing  T-cell 
responses or activities have been demonstrated in both humoral and cellular immune 
responses. There are experimental systems in which restrictions between helper T cells 
and Mth in the development of antibody responses in vitro are different from those in 
the GAT system. For some antigens, such as ovalbumin and keyhole limpet hemocy- 
anin, no requirement for syngenicity between M~ and carrier-primed helper T  cells 
in the development of secondary antibody responses to hapten-carrier conjugates by 
hapten-primed B cells has been demonstrated (21).  In contrast to primary responses 
in the GAT system where M~-T-cell interactions are not restricted, primary IgM anti- 
TNP  PFC  responses  to  trinitrophenol  (TNP)-(T,G)-A-L  by  lymphoid  cells  from 
aj. Kapp. Manuscript in preparation. 
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(responder ×  nonresponder)F1 mice developed only in the presence of responder, but 
not nonresponder, parental Mq~ (9). These results suggest expression of Ir gene control 
at the level of the M4*. This observation is also in contrast to the GAT system, where 
responder and nonresponder parental GAT-Mq~ stimulate comparable primary IgG 
PFC responses by (responder ×  nonresponder)Fa lymphoid cells (22). Further second- 
ary  anti-TNP  responses  in  cultures  containing  (T,G)-A-L-primed  (responder  X 
nonresponder)F1 T  cells and TNP-primed responder parental B cells develop only in 
the presence of responder parental Mq~ (23). Thus, development of both primary and 
secondary responses to TNP-(T,G)-A-L appear to involve genetic restrictions govern- 
ing M~-T-cell interactions. Whether the differences in results in the GAT and (T,G)- 
A-L  systems  reflect  different  culture  and  assay  procedures  or  differences  in  M~ 
function with respect to Ir gene product expression awaits further investigation. 
Summary 
Virgin  spleen  cells  develop comparable  primary  antibody  responses  in  vitro  to 
syngeneic or allogeneic macrophages (M~) bearing the terpolymer L-glutamic acid  6°- 
c-alanineZ°-c-tyrosine  1° (GAT), whereas immune spleen cells primed with syngeneic 
or allogeneic GAT-M4~ develop secondary responses preferentially when stimulated 
with GAT-M4~ syngeneic to the GAT-M4~ used for priming in vivo. These restrictions 
are mediated by products of the I-A subregion of the H-2 complex and are operative 
at the level of the GAT-M4,-immune helper T-cell interactions. To investigate why 
these immune spleen cells fail to develop a significant antibody response to GAT-M~ 
other than  those used  for in  vivo immunization  and  determine the mechanism  by 
which the restriction is maintained, spleen cells from virgin and syngeneic or allogeneic 
GAT-M&primed  mice  were  co-cultured  in  the  presence  of GAT-M~  of various 
haplotypes. Antibody responses to GAT developed only in the presence of GAT-Mq, 
syngeneic to the MS used for in vivo priming;  responses in cultures with GAT-M~ 
allogeneic to the priming M4~, whether these Mq~ were syngeneic or allogeneic with 
respect to the responding spleen cells, were suppressed. The suppression was mediated 
by GAT-specific radiosensitive T cells. Thus, development of GAT-specific suppressor 
T  cells  appears  to  be  a  natural  consequence of the  immune  response  to  GAT  in 
responder as well as nonresponder mice. The implications of stimulation of genetically 
restricted immune helper T  cells, and antigen-specific, but unrestricted, suppressor T 
cells  after  immunization  with  GAT-M4~  in  vivo  are  discussed  in  the  context  of 
regulatory mechanisms in antibody responses. 
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